Treatment of venous thromboembolism during pregnancy

Thrombosis Research

Volumn 123, Issue SUPPL. 2, 2009, Pages

  Bauersachs, Rupert M ^a  

^a KLINIKUM DARMSTADT   (Germany)

Author keywords

Deep vein thrombosis; Heparin; Low molecular weight; Pregnancy; Pulmonary embolism; Thromboembolism; Treatment; Venous

Indexed keywords

ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN;

ARTICLE; FEMALE; HUMAN; PREGNANCY; PREGNANCY COMPLICATION; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; VENOUS THROMBOEMBOLISM;

EID: 65549142967     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/S0049-3848(09)70010-6     Document Type: Article

References (39)

1. Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: A systematic review of safety and efficacy. Blood 2005 Jul 15;106(2):401-7.
2. Kher A, Bauersachs R, Nielsen JD. The management of thrombosis in pregnancy: Role of low-molecular-weight heparin. Thromb Haemost 2007 Apr;97(4):505 13.
3. Schindewolf M, Magnani HN, Lindhoff-Last E. [Danaparoid in pregnancy in cases of heparin intolerance use in 59 cases]. Hamostaseologie 2007 May;27(2):89 97.
4. Gerhardt A, Zotz RB, Stockschlaeder M, Scharf RE. Fondaparinux is an effective alternative anticoagulant in pregnant women with high risk of venous thromboembolism and intolerance to low-molecularweight heparins and heparinoids. Thromb Haemost 2007 Mar;97(3):496-7.
5. Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008 Jun;133(6 Suppl):844S 886S.
6. Schaefer C, Hannemann D, Meister R, Elefant E, Paulus W, Vial T, et al. Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study. Thromb Haemost 2006 Jun;95(6):949-57.
7. Hall JG, Pauli RM, Wilson KM. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 1980 Jan; 68(1):122 40.
8. Ginsberg JS, Hirsh J. Use of antithrombotic agents during pregnancy. Chest 1995 Oct;108(4 Suppl):305S 311S.
9. Pettila V, Kaaja R, Leinonen P, Ekblad U, Kataja M, Ikkala E. Thromboprophylaxis with low molecular weight heparin (dalteparin) in pregnancy. Thromb Res 1999 Nov 15;96(4): 275-82.
10. Pettila V, Leinonen P, Markkola A, Hiilesmaa V, Kaaja R. Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin. Thromb Haemost 2002 Feb;87(2):182-6.
11. van Dongen CJ, van den Belt AG, Prins MH, Lensing AW. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database Syst Rev 2004(4): CD001100.
12. Deruelle P, Coulon C. The use of low-molecular-weight heparins in pregnancy how safe are they? Curr Opin Obstet Gynecol 2007 Dec;19(6):573-7.
13. Rodger MA, Kahn SR, Cranney A, Hodsman A, Kovacs MJ, Clement AM, et al. Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density: Substudy of a randomized controlled trial. J Thromb Haemost 2007 Aug;5(8):1600-6.
14. Bauersachs RM, Dudenhausen J, Faridi A, Fischer T, Fung S, Geisen U, et al. Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women. Thromb Haemost 2007 Dec;98(6):1237 45.
15. Rai R, Regan L. Antiphospholipid syndrome in pregnancy: A randomized, controlled trial of treatment. Obstet Gynecol 2002 Dec;100(6):1354.
16. Ray JG, Chan WS. Deep vein thrombosis during pregnancy and the puerperium: A meta-analysis of the period of risk and the leg of presentation. Obstet Gynecol Surv 1999 Apr;54(4):265 71.
17. Blanco-Molina A, Trujillo-Santos J, Criado J, Lopez L, Lecumberri R, Gutierrez R, et al. Venous thromboembolism during pregnancy or postpartum: Findings from the RIETE Registry. Thromb Haemost 2007 Feb;97(2): 186 90.
18. Voke J, Keidan J, Pavord S, Spencer NH, Hunt BJ. The management of antenatal venous thromboembolism in the UK and Ireland: A prospective multicentre observational survey. Br J Haematol 2007 Nov;139(4):545 58.
19. Knight M. Antenatal pulmonary embolism: Risk factors, management and outcomes. Br J Obstet Gynaecol 2008 Mar;115(4):453-61.
20. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008 Jun;133(6 Suppl):454S 545S.
21. Greer IA. Prevention of venous thromboembolism in pregnancy. Eur J Med Res 2004 Mar 30;9(3):135 45.
22. Hull RD, Pineo GF, Brant RF, Mah AF, Burke N, Dear R, et al. Self-managed long-term low-molecular-weight heparin therapy: The balance of benefits and harms. Am J Med 2007 Jan;120(1):72-82.
23. van Der Heijden JF, Hutten BA, Buller HR, Prins MH. Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism. Cochrane Database Syst Rev 2000(4): CD002001.
24. Greer IA. Thrombosis in pregnancy: Maternal and fetal issues. Lancet 1999 Apr 10;353(9160):1258 65.
25. Casele HL, Laifer SA, Woelkers DA, Venkataramanan R. Changes in the pharmacokinetics of the low-molecularweight heparin enoxaparin sodium during pregnancy. Am J Obstet Gynecol 1999 Nov;181(5 Pt 1):1113-7.
26. Sephton V, Farquharson RG, Topping J, Quenby SM, Cowan C, Back DJ, et al. A longitudinal study of maternal dose response to low molecular weight heparin in pregnancy. Obstet Gynecol 2003 Jun;101(6):1307 11.
27. Smith MP, Norris LA, Steer PJ, Savidge GF, Bonnar J. Tinzaparin sodium for thrombosis treatment and prevention during pregnancy. Am J Obstet Gynecol 2004 Feb;190(2):495 501.
28. Greer I, Hunt BJ. Low molecular weight heparin in pregnancy: Current issues. Br J Haematol 2005 Mar; 128(5):593 601.
29. Favaloro EJ, Bonar R, Aboud M, Low J, Sioufi J, Wheeler M, et al. How useful is the monitoring of (low molecular weight) heparin therapy by anti-Xa assay? A laboratory perspective. Lab Hematol 2005;11(3):157 62.
30. Bates SM, Greer IA, Hirsh J, Ginsberg JS. Use of antithrombotic agents during pregnancy: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004 Sep;126(3 Suppl):627S 644S.
31. Rodie VA, Thomson AJ, Stewart FM, Quinn AJ, Walker ID, Greer IA. Low molecular weight heparin for the treatment of venous thromboembolism in pregnancy: A case series. Br J Obstet Gynaecol 2002 Sep;109(9):1020-4.
32. Macklon NS, Greer IA, Bowman AW. An ultrasound study of gestational and postural changes in the deep venous system of the leg in pregnancy. Br J Obstet Gynaecol 1997 Feb;104(2):191-7.
33. Hunt BJ, Doughty HA, Majumdar G, Copplestone A, Kerslake S, Buchanan N, et al. Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies. Thromb Haemost 1997 Jan;77(1):39-43.
34. Lee AY, Levine MN, Baker RI, Bowden C, Kakkar AK, Prins M, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 2003 Jul 10;349(2): 146 53.
35. James AH. Prevention and management of venous thromboembolism in pregnancy. Am J Med 2007 Oct; 120(10 Suppl 2):S26-34.
36. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008 Jun;133(6 Suppl):381S 453S.
37. Brandjes DP, Buller HR, Heijboer H, Huisman MV, de Rijk M, Jagt H, et al. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 1997 Mar 15;349(9054):759 62.
38. Casele H, Haney EI, James A, Rosene-Montella K, Carson M. Bone density changes in women who receive thromboprophylaxis in pregnancy. Am J Obstet Gynecol 2006 Oct;195(4):1109 13.
39. Mahomed K, Gulmezoglu AM. Vitamin D supplementation in pregnancy. Cochrane Database Syst Rev 2000(2): CD000228.